Lantheus Holdings Inc (LNTH) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $75.43
• Market Cap: $5.15B
• P/E Ratio: 31.42
• EPS: $2.41
• 52-Week High: $111.29
• 52-Week Low: $47.25

Market Sentiment

Lantheus Holdings Inc currently has a Bullish sentiment score of 0.26.

About Lantheus Holdings Inc

Lantheus Holdings, Inc. is a prominent biotechnology company headquartered in North Billerica, Massachusetts, specializing in the development, manufacturing, and commercialization of innovative diagnostic and therapeutic agents aimed at treating serious medical conditions, particularly in oncology and cardiology. The company is recognized for its cutting-edge PET imaging agents, which are essential for accurate cancer diagnosis and management, thereby enhancing patient care. Lantheus is commi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Lantheus Holdings Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LNTH pay dividends?

Lantheus Holdings Inc (LNTH) does not currently pay a regular dividend.

What is LNTH's P/E ratio?

Lantheus Holdings Inc has a price-to-earnings (P/E) ratio of 31.42.

What is LNTH's market cap?

Lantheus Holdings Inc (LNTH) has a market capitalization of $5.15B with a current stock price of $75.43.